A phase II study of phenesterin (NSC-104469)
โ Scribed by Bennett, J. M. ;Frank, J. ;Sears, M. ;Lagakos, S. W. ;Horton, J. ;Colsky, J. ;Hall, T. C. ;,
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- English
- Weight
- 327 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Phenesterin was evaluated in 222 patients with two different dosage regimens, one by daily treatment and the other with an intermittent schedule. Toxicity was moderate with both programs. The largest group of patients treated had breast cancer; they experienced a 10% response rate. Of interest was a higher percentage of responses in ovarian cancer (36%). An expanded study of patients with ovarian cancer would be of interest.
๐ SIMILAR VOLUMES
Seventeen patients with disseminated malignant melanoma received a daily oral regimen of tamoxifen, 100 mg/m2. All patients had prior chemotherapy and predominantly visceral involvement. None of the patients had an objective regression and most (71%) had progressive disease at the time of first reas